BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32932544)

  • 1. von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli.
    Murphy SJX; Lim ST; Hickey F; Kinsella JA; Smith DR; Tierney S; Egan B; Feeley TM; Murphy SM; Collins DR; Coughlan T; O'Neill D; Harbison JA; Madhavan P; O'Neill SM; Colgan MP; O'Donnell JS; O'Sullivan JM; Hamilton G; McCabe DJH
    Thromb Haemost; 2021 Jan; 121(1):86-97. PubMed ID: 32932544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased endothelial activation in recently symptomatic versus asymptomatic carotid artery stenosis and in cerebral microembolic-signal-negative patient subgroups.
    Kinsella JA; Tobin WO; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Feeley TM; Egan B; O'Neill D; Collins RD; Coughlan T; Harbison JA; Doherty CP; Madhavan P; Moore DJ; O'Neill SM; Colgan MP; Saqqur M; Murphy RP; Moran N; Hamilton G; McCabe DJ
    Eur J Neurol; 2014 Jul; 21(7):969-e55. PubMed ID: 24712648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet activation in early symptomatic vs. asymptomatic carotid stenosis and relationship with microembolic status: results from the Platelets and Carotid Stenosis Study.
    Kinsella JA; Tobin WO; Tierney S; Feeley TM; Egan B; Collins DR; Coughlan T; O'Neill D; Harbison J; Madhavan P; Moore DJ; O'Neill SM; Colgan MP; Doherty CP; Murphy RP; Saqqur M; Moran N; Hamilton G; McCabe DJ
    J Thromb Haemost; 2013 Jul; 11(7):1407-16. PubMed ID: 23621656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke.
    McCabe DJ; Murphy SJ; Starke R; Harrison P; Brown MM; Sidhu PS; Mackie IJ; Scully M; Machin SJ
    J Neurol Sci; 2015 Jan; 348(1-2):35-40. PubMed ID: 25498844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased thrombin generation potential in symptomatic versus asymptomatic moderate or severe carotid stenosis and relationship with cerebral microemboli.
    Kinsella JA; Tobin WO; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Feeley TM; Egan B; O'Neill D; Collins DR; Coughlan T; Harbison JA; Doherty CP; Madhavan P; Moore DJ; O'Neill SM; Colgan MP; Saqqur M; Murphy RP; Moran N; Hamilton G; McCabe DJ
    J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):460-7. PubMed ID: 25033981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
    Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
    J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous assessment of plaque morphology, cerebral micro-embolic signal status and platelet biomarkers in patients with recently symptomatic and asymptomatic carotid stenosis.
    Murphy SJ; Lim ST; Kinsella JA; Tierney S; Egan B; Feeley TM; Dooley C; Kelly J; Murphy SM; Walsh RA; Collins R; Coughlan T; O'Neill D; Harbison JA; Madhavan P; O'Neill SM; Colgan MP; Meaney JF; Hamilton G; McCabe DJ
    J Cereb Blood Flow Metab; 2020 Nov; 40(11):2201-2214. PubMed ID: 31711341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome.
    Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Tsuda K; Kondo M; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):622-630. PubMed ID: 26759371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of 'on-treatment platelet reactivity' and relationship with cerebral micro-embolic signals in asymptomatic and symptomatic carotid stenosis.
    Kinsella JA; Oliver Tobin W; Tierney S; Feeley TM; Egan B; Coughlan T; Ronan Collins D; O'Neill D; Harbison JA; Doherty CP; Madhavan P; Moore DJ; O'Neill SM; Colgan MP; Saqqur M; Murphy RP; Moran N; Hamilton G; McCabe DJH
    J Neurol Sci; 2017 May; 376():133-139. PubMed ID: 28431600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ADAMTS13-von Willebrand factor axis in COVID-19 patients.
    Mancini I; Baronciani L; Artoni A; Colpani P; Biganzoli M; Cozzi G; Novembrino C; Boscolo Anzoletti M; De Zan V; Pagliari MT; Gualtierotti R; Aliberti S; Panigada M; Grasselli G; Blasi F; Peyvandi F
    J Thromb Haemost; 2021 Feb; 19(2):513-521. PubMed ID: 33230904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases.
    Habe K; Wada H; Ito-Habe N; Hatada T; Matsumoto T; Ohishi K; Maruyama K; Imai H; Mizutani H; Nobori T
    Thromb Res; 2012 May; 129(5):598-602. PubMed ID: 22070827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation.
    Takahashi N; Wada H; Usui M; Kobayashi T; Habe-Ito N; Matsumoto T; Uemoto S; Nobori T; Isaji S
    Thromb Res; 2013 Mar; 131(3):225-9. PubMed ID: 23266519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
    Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
    World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet count and reticulated platelets in recently symptomatic versus asymptomatic carotid artery stenosis and in cerebral microembolic signal-negative patient subgroups: results from the HaEmostasis In carotid STenosis (HEIST) study.
    Murphy SJX; Lim ST; Kinsella JA; Murphy D; Enright HM; McCabe DJH;
    J Neurol; 2018 May; 265(5):1037-1049. PubMed ID: 29476243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
    Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
    BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between 'on-treatment platelet reactivity', shear stress, and micro-embolic signals in asymptomatic and symptomatic carotid stenosis.
    Murphy SJX; Lim ST; Kinsella JA; Tierney S; Egan B; Feeley TM; Murphy SM; Walsh RA; Collins DR; Coughlan T; O'Neill D; Harbison JA; Madhavan P; O'Neill SM; Colgan MP; Cox D; Moran N; Hamilton G; Meaney JF; McCabe DJH
    J Neurol; 2020 Jan; 267(1):168-184. PubMed ID: 31606758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome.
    Taylor A; Vendramin C; Singh D; Brown MM; Scully M
    Blood Adv; 2020 Jan; 4(2):398-407. PubMed ID: 31990334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study.
    Pagliari MT; Rosendaal FR; Ahmadinejad M; Badiee Z; Baghaipour MR; Baronciani L; Benítez Hidalgo O; Bodó I; Budde U; Castaman G; Eshghi P; Goudemand J; Karimi M; Keikhaei B; Lassila R; Leebeek FWG; Lopez Fernandez MF; Mannucci PM; Marino R; Oldenburg J; Peake I; Santoro C; Schneppenheim R; Tiede A; Toogeh G; Tosetto A; Trossaert M; Yadegari H; Zetterberg EMK; Peyvandi F; Federici AB; Eikenboom J
    J Thromb Haemost; 2022 May; 20(5):1106-1114. PubMed ID: 35092343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome.
    Stufano F; Boscarino M; Bucciarelli P; Baronciani L; Maino A; Cozzi G; Peyvandi F
    Semin Thromb Hemost; 2019 Feb; 45(1):36-42. PubMed ID: 29913537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease.
    Sanders YV; Groeneveld D; Meijer K; Fijnvandraat K; Cnossen MH; van der Bom JG; Coppens M; de Meris J; Laros-van Gorkom BA; Mauser-Bunschoten EP; Leebeek FW; Eikenboom J;
    Blood; 2015 May; 125(19):3006-13. PubMed ID: 25673639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.